Test License [Regulatives / Guidelines]

posted by wienui  – Germany, Oman, 2018-10-07 21:04 (842 d 15:02 ago) – Posting: # 19414
Views: 1,432

Dear RK,

» I applied Test license for some X drug in India, I got permission and I imported the drug (reference) from outside India then conducted one study (pilot). Now I want to conduct one more study (pivotal) with remaining quantity of Reference drug from first study. Here I have some doubts:

» 1) Can I use remaining quantity of reference drug for pivotal
No, You can't use the rest of the reference drug for conducting a BE Study with a new ordered reference drug batch, as they are two different Batches ( Biobatches).

» 2) If we use remaining IPs, Is we need to get Test license permission for pivotal.

Yes, you will need.

Regards,

Osama

Cheers,
Osama

Complete thread:

Activity
 Admin contact
21,316 posts in 4,446 threads, 1,489 registered users;
online 4 (0 registered, 4 guests [including 2 identified bots]).
Forum time: Wednesday 11:07 CET (Europe/Vienna)

Nothing fails like success because you do not learn anything from it.
The only thing we ever learn from is failure.
Success only confirms our superstitions.    Kenneth E. Boulding

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5